65 related articles for article (PubMed ID: 698934)
1. Antiproliferative agents and differential survival between normal and cancer cells.
Tsuboi KK; Kwong LK
Cancer Res; 1978 Nov; 38(11 Pt 1):3745-50. PubMed ID: 698934
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells.
Tsuboi KK; Edmunds NH; Kwong LK
Cancer Res; 1977 Sep; 37(9):3080-7. PubMed ID: 884665
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
4. m-AMSA and PALA: two new agents in cancer chemotherapy.
Rozencweig M; Von Hoff DD; Cysyk RL; Muggia FM
Cancer Chemother Pharmacol; 1979; 3(3):135-41. PubMed ID: 393427
[TBL] [Abstract][Full Text] [Related]
5. [Biochemical modulation of 5-FU by thymidine and N-phosphoacetyl-L-aspartate: the relation between 5-FU incorporation into RNA and its cytocidal effect].
Akazawa S; Kumai R; Shimizu K; Ayusawa D; Seno T; Yoshida S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):990-5. PubMed ID: 3963863
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.
Ardalan B; Glazer RI; Kensler TW; Jayaram HN; Van Pham T; Macdonald JS; Cooney DA
Biochem Pharmacol; 1981 Aug; 30(15):2045-9. PubMed ID: 7295324
[No Abstract] [Full Text] [Related]
7. Lethal and cytokinetic effects of anguidine on a human colon cancer cell line.
Dosik GM; Barlogie B; Johnston DA; Murphy WK; Drewinko B
Cancer Res; 1978 Oct; 38(10):3304-9. PubMed ID: 688220
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase.
Johnson RK; Swyryd EA; Stark GR
Cancer Res; 1978 Feb; 38(2):371-8. PubMed ID: 620408
[No Abstract] [Full Text] [Related]
9. Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.
Baillon J; Guichard M; Malaise EP; Hervé G
Cancer Res; 1983 May; 43(5):2277-82. PubMed ID: 6831451
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth by N-(phosphonacetyl)-L-aspartate in human and murine cells in vitro.
Leyva A; Appel H; Smith P; Lankelma J; Pinedo HM
Cancer Lett; 1981 Mar; 12(1-2):169-73. PubMed ID: 7273001
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
Fernandez-Pol JA; Klos DJ; Hamilton PD
Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229
[TBL] [Abstract][Full Text] [Related]
12. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
13. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Germain GS; Grindey GB; Witt BC; Houghton JA
Cancer Res; 1990 Jan; 50(2):318-22. PubMed ID: 2295071
[TBL] [Abstract][Full Text] [Related]
14. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
Bergerat JP; Barlogie B; Drewinko B
Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
[TBL] [Abstract][Full Text] [Related]
15. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
Liang CM; Donehower RC; Chabner BA
Mol Pharmacol; 1982 Jan; 21(1):224-30. PubMed ID: 6813676
[No Abstract] [Full Text] [Related]
16. TPA enhancement of the recovery of methotrexate and N-phosphonacetyl L-aspartate resistant mouse 3T6 cell clones is associated with transient alterations of cell cycle progression.
Szallasi A; Fox M; Kinsella AR
Int J Cancer; 1988 Jul; 42(1):84-6. PubMed ID: 3391707
[TBL] [Abstract][Full Text] [Related]
17. Marked radiosensitization of cells in culture to X ray by 5-chlorodeoxycytidine coadministered with tetrahydrouridine, and inhibitors of pyrimidine biosynthesis.
Perez LM; Mekras JA; Briggle TV; Greer S
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1453-8. PubMed ID: 6236189
[TBL] [Abstract][Full Text] [Related]
18. Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells.
Jacobsen LB; Putnam JE; Sawick DP; Cassady JM; Morré DJ
Life Sci; 1988; 42(8):913-8. PubMed ID: 3343891
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review.
Grem JL; King SA; O'Dwyer PJ; Leyland-Jones B
Cancer Res; 1988 Aug; 48(16):4441-54. PubMed ID: 3293772
[No Abstract] [Full Text] [Related]
20. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
Johnson RK; Inouye T; Goldin A; Stark GR
Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
